Pharmacy technician home visits feasible for housebound polypharmacy patients

This feasibility study demonstrates that a pharmacy technician-clinical pharmacist domiciliary model can reach housebound older adults in deprived areas who miss routine long-term condition reviews, generating actionable medication and clinical interventions.

pharmacy technicianclinical pharmacistdomiciliary medication reviewpolypharmacyhousebound older adultsdeprescribinganticholinergic burdenfeasibility studygeriatric pharmacyhealth inequalitiesCAHPS Geriatrics / Geriatric Pharmacy

Background Information

Home pharmacy visits reduce falls and improve life quality in elderly.

Housebound elderly patients in deprived areas often miss critical long-term condition reviews, leading to poorer health outcomes. Following 83 pharmacy technician visits, medication adjustments were made, falls reduced to zero, quality-of-life scores improved, and unscheduled care decreased. The study shows the feasibility of pharmacy technician-led home visits, highlighting potential implications for expanding pharmacy roles in community care. Limitations include a small sample size and short follow-up period. Pharmacy technician-led home visits can improve health outcomes for housebound elderly patients.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.

Subscribe for Full Access →

Authors: Ramos T, Cochrane L, Verma A, Zhang L, Beattie A, Johnson CF, Lowrie R

Citation: Ramos T, Cochrane L, Verma A, et al. Feasibility study of the Care-at-Home Pharmacotherapy Service (CAHPS): pharmacy technician-led home visits for people receiving polypharmacy who are housebound living in socioeconomically deprived areas. International journal of clinical pharmacy. 2026. doi:10.1007/s11096-026-02211-2

Article Links: PubMed · Journal / DOI

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

Thanks for the feedback!

🔒

Deep Analysis: Subscribers Only

Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.

Executive Summary

Study Design

Patient Population

Primary Outcomes

Secondary Outcomes & Safety Profile

Pharmacist Implications

Clinical Pearls

Limitations

Controversies & Evidence Gaps

Cost & Logistics

Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →